Similar articles for PMID: 18314442

Year	Number of Results
2001	1
2002	3
2003	2
2004	2
2005	4
2006	11
2007	13
2008	13
2009	16
2010	15
2011	26
2012	18
2013	13
2014	16
2015	7
2016	3
2017	3
2018	5
2019	7
2020	8
2021	11
2022	15
2023	7
2024	0

1

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N, Davis RS. Li FJ, et al. Blood. 2008 Jul 1;112(1):179-87. doi: 10.1182/blood-2008-01-131359. Epub 2008 Feb 26. Blood. 2008. PMID: 18314442 Free PMC article.

2

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia.

Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC, Kay NE, Brown JR, Gribben JG, Neuberg DS, He F, Greaves AW, Rai KR, Kipps TJ. Rassenti LZ, et al. Blood. 2008 Sep 1;112(5):1923-30. doi: 10.1182/blood-2007-05-092882. Epub 2008 Jun 24. Blood. 2008. PMID: 18577710 Free PMC article.

3

FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.

Nückel H, Collins CH, Frey UH, Sellmann L, Dürig J, Siffert W, Dührsen U. Nückel H, et al. Eur J Haematol. 2009 Dec 1;83(6):541-9. doi: 10.1111/j.1600-0609.2009.01328.x. Epub 2009 Aug 4. Eur J Haematol. 2009. PMID: 19682311

4

Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL.

Morilla A, Gonzalez de Castro D, Del Giudice I, Osuji N, Else M, Morilla R, Brito Babapulle V, Rudenko H, Matutes E, Dearden C, Catovsky D, Morgan GJ. Morilla A, et al. Leuk Lymphoma. 2008 Nov;49(11):2108-15. doi: 10.1080/10428190802360810. Leuk Lymphoma. 2008. PMID: 19021053

5

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM. Wiestner A, et al. Blood. 2003 Jun 15;101(12):4944-51. doi: 10.1182/blood-2002-10-3306. Epub 2003 Feb 20. Blood. 2003. PMID: 12595313 Free article.

6

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.

Nichols EM, Jones R, Watson R, Pepper CJ, Fegan C, Marchbank KJ. Nichols EM, et al. Oncotarget. 2015 Oct 20;6(32):32669-80. doi: 10.18632/oncotarget.5404. Oncotarget. 2015. PMID: 26452134 Free PMC article.

7

Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.

Xu W, Cao X, Miao KR, Qiao C, Wu YJ, Liu Q, Fan L, Li JY. Xu W, et al. Int J Hematol. 2009 Sep;90(2):205-211. doi: 10.1007/s12185-009-0380-8. Epub 2009 Jul 24. Int J Hematol. 2009. PMID: 19629630

8

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.

Hüttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nückel H, Ebeling P, Führer A, Edelmann J, Sellmann L, Dührsen U, Dürig J. Hüttmann A, et al. Leukemia. 2006 Oct;20(10):1774-82. doi: 10.1038/sj.leu.2404363. Epub 2006 Aug 17. Leukemia. 2006. PMID: 16932341

9

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J. Schroers R, et al. Leukemia. 2005 May;19(5):750-8. doi: 10.1038/sj.leu.2403707. Leukemia. 2005. PMID: 15759031

10

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Morabito F, Mosca L, Cutrona G, Agnelli L, Tuana G, Ferracin M, Zagatti B, Lionetti M, Fabris S, Maura F, Matis S, Gentile M, Vigna E, Colombo M, Massucco C, Recchia AG, Bossio S, De Stefano L, Ilariucci F, Musolino C, Molica S, Di Raimondo F, Cortelezzi A, Tassone P, Negrini M, Monti S, Rossi D, Gaidano G, Ferrarini M, Neri A. Morabito F, et al. Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13. Clin Cancer Res. 2013. PMID: 24036852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

187 results

Results by year